Utah’s hottest biotech firm, Recursion Pharmaceuticals, is taking advantage of the red hot stock market as it has announced plans for a $100 million Initial Public Offering.
Share this post
Recursion Pharma is Going Public
Share this post
Utah’s hottest biotech firm, Recursion Pharmaceuticals, is taking advantage of the red hot stock market as it has announced plans for a $100 million Initial Public Offering.